BRIEF published on 04/23/2025 at 07:05, 1 year 3 months ago Innate Pharma Takes Back Rights and Sanofi Considers Investment Strategic Investment Sanofi Innate Pharma Acute Myeloid Leukemia CD123
PRESS RELEASE published on 04/23/2025 at 07:00, 1 year 3 months ago Inside Information / Other news releases Innate Pharma regains rights on CD123 targeting ANKET® as Sanofi plans strategic investment. SAR'579 (IPH6101) ongoing study shows promise in AML patients Strategic Investment Sanofi Innate Pharma CD123 Targeting SAR'579
BRIEF published on 04/16/2025 at 07:05, 1 year 3 months ago Innate Pharma General Meeting Announced for May 22, 2025 Shareholders Biotechnology General Meeting Innate Pharma Marseille
BRIEF published on 04/03/2025 at 13:24, 1 year 4 months ago Innate Pharma participates in the Stifel 2025 Virtual Targeted Oncology Forum Euronext Paris Oncology Immunotherapy Innate Pharma Virtual Forum
BRIEF published on 04/03/2025 at 13:18, 1 year 4 months ago Innate Pharma to Engage in Stifel 2025 Virtual Oncology Forum Biotechnology Immunotherapy Virtual Event Innate Pharma Oncology Forum 2025
PRESS RELEASE published on 04/03/2025 at 13:13, 1 year 4 months ago INSIDE INFORMATION / OTHER NEWS RELEASES Innate Pharma to participate in 2025 Stifel Virtual Targeted Oncology Forum. Executive team presenting and hosting 1x1 meetings. Focus on innovative cancer immunotherapies Cancer Innate Pharma Immunothérapies Stifel Targeted Oncology Forum
PRESS RELEASE published on 03/28/2025 at 14:37, 1 year 4 months ago Annual financial and audit reports / Annual financial report
BRIEF published on 03/20/2025 at 07:05, 1 year 4 months ago Innate Pharma Announces 2024 Financial Results Conference Financial Results Conference Call Stock Market Listing Cancer Immunotherapy Innate Pharma
PRESS RELEASE published on 03/20/2025 at 07:00, 1 year 4 months ago Inside Information / Other news releases Innate Pharma to hold conference call and webcast for full year 2024 financial results on March 27, 2025. Details for participation provided Financial Results Conference Call Biotechnology Webcast Innate Pharma
BRIEF published on 02/17/2025 at 07:07, 1 year 5 months ago Innate Pharma Receives Breakthrough Therapy Designation from FDA FDA Innate Pharma Breakthrough Therapy Lacutamab Sézary Syndrome
Published on 08/06/2026 at 03:35, 2 hours 34 minutes ago Tunkillia Upgrade Drilling – 39,000m Phase 2 Complete Targeting JORC Resource Classification Upgrades; PFS Underway
Published on 08/06/2026 at 01:40, 4 hours 29 minutes ago Taranis Identifies a Hydrothermally Altered, Sulfide-Bearing Intrusive Stock Associated with Historic Gold-Silver Occurrence and Connected to Thor
Published on 08/05/2026 at 23:40, 6 hours 29 minutes ago Galantas Gold Secures Key Permitting Approvals for Andacollo Gold Project
Published on 08/05/2026 at 23:10, 6 hours 59 minutes ago Ur-Energy Announces Date for Second Quarter 2026 Results and Conference Call and Webcast
Published on 08/05/2026 at 23:01, 7 hours 8 minutes ago Full Circle Lithium Announces Extension of Current Private Placement
Published on 08/05/2026 at 23:23, 6 hours 46 minutes ago EQS-Adhoc: Enapter AG: Agreement with Patrimonium to discharge corporate bond liabilities of around EUR 26 million; realignment to an asset-light business model; capital measure planned
Published on 08/05/2026 at 23:04, 7 hours 5 minutes ago AUTODOC to publish H1 2026 report and host a conference call on Q2 results on 13 August 2026
Published on 08/05/2026 at 19:14, 10 hours 55 minutes ago 2CRSi informs the market about the governance of AETHER Infrastructures and the progress of the AETHER project in which 2CRSi takes part as a member of the consortium
Published on 08/05/2026 at 18:30, 11 hours 39 minutes ago Avolta enters Kolkata Airport, growing duty-free presence in India
Published on 08/05/2026 at 18:00, 12 hours 9 minutes ago Information concerning the total number of voting rights and shares in the share capital as of July 31, 2026
Published on 08/05/2026 at 17:49, 12 hours 19 minutes ago Mersen: Number of shares and voting rights as of July 31, 2026
Published on 08/05/2026 at 17:45, 12 hours 24 minutes ago Information concerning the total number of voting rights and shares 2026 07 31
Published on 08/05/2026 at 17:45, 12 hours 24 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 08/05/2026 at 17:42, 12 hours 27 minutes ago Aéroports de Paris SA - Shares and voting rights as of 31 July 2026
